Next-generation sequencing service

Foreshadowing the changes in the next-generation sequencing market, AGRF is expanding its current range of next-generation sequencing services via the acquisition of the illumina Genome Analyser II (GA II, utilising Solexa technology). The GA II service, combined with the established Roche GS FLX (454) service, will enable the genomics research community to access a suite of scalable next-generation sequencing services spanning both long and short read lengths.

The development of long tag and short tag sequencing technologies has resulted in a range of applications leading to the generation of data previously unobtainable in such a short time. The GS FLX generates longer reader lengths for applications including de novo genome sequencing and re-sequencing. Applications that use short reads, but require greater sequencing depth at a lower cost, including digital gene expression and ChIP-Seq, can now be performed by AGRF using the GA II.

The expansion of AGRF’s next-generation sequencing service will complement the Sanger-based sequencing service. This service, combined with AGRF’s bioinformatics capability, will enable the provision of a broader range of genomic service solutions.